Exon expression and alternatively spliced genes in tourette syndrome

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 1, 2011, Pages 72-78

  Tian, Yingfang ^a   Liao, Isaac H ^a   Zhan, Xinhua ^a   Gunther, Joan R ^a   Ander, Bradley P ^a   Liu, Dazhi ^a   Lit, Lisa ^a   Jickling, Glen C ^a   Corbett, Blythe A ^a   Bos Veneman, Netty G P ^b   Hoekstra, Pieter J ^b   Sharp, Frank R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alternative splicing; Blood biomarker; Exon expression profiles; Gene expression profiling; Tourette Syndrome

Indexed keywords

CHOLESTANETRIOL 26 MONOOXYGENASE; MESSENGER RNA;

3' UNTRANSLATED REGION; ADOLESCENT; AMINO ACID METABOLISM; ARTICLE; CELL COMMUNICATION; CELL MATURATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; PRIORITY JOURNAL; RNA SEQUENCE; RNA SPLICING; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; ALTERNATIVE RNA SPLICING; CASE CONTROL STUDY; DEMOGRAPHY; DNA MICROARRAY; GENETICS; METABOLISM;

ADOLESCENT; ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; CHILD; DEMOGRAPHY; EXONS; FEMALE; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TOURETTE SYNDROME;

EID: 79953663344     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31140     Document Type: Article

References (47)

1. Achiron A, Gurevich M. 2006. Peripheral blood gene expression signature mirrors central nervous system disease: The model of multiple sclerosis. Autoimmun Rev 5: 517-522.
2. Affymetrix, white paper. Identifying and validating alternative splicing variants. http://www.affymetrix.com/support/support_result.affx. p10.
3. APA. 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th edition text revision. Washington, DC: American Psychiatric Association.
4. Baym CL, Corbett BA, Wright SB, Bunge SA. 2008. Neural correlates of tic severity and cognitive control in children with Tourette syndrome. Brain 131: 165-179.
5. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
6. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D. 2005. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA 102: 11023-11028.
7. Cuperlovic-Culf M, Belacel N, Culf AS, Ouellette RJ. 2006. Microarray analysis of alternative splicing. OMICS 10: 344-357.
8. Faustino NA, Cooper TA. 2003. Pre-mRNA splicing and human disease. Genes Dev 17: 419-437.
9. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasik R, Khanlou N, Han M, Liew CC, Tsuang MT. 2005. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci USA 102: 15533-15538.
10. Hong JJ, Loiselle CR, Yoon DY, Lee O, Becker KG, Singer HS. 2004. Microarray analysis in Tourette syndrome postmortem putamen. J Neurol Sci 225: 57-64.
11. Kawashima K, Fujii T. 2003. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 74: 675-696.
12. Kawikova I, Leckman JF, Kronig H, Katsovich L, Bessen DE, Ghebremichael M, Bothwell AL. 2007. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: A preliminary study. Biol Psychiatry 61: 273-278.
13. Kohm AP, Sanders VM. 2001. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53: 487-525.
14. Leckman JF. 2002. Tourette's syndrome. Lancet 360: 1577-1586.
15. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. 1989. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28: 566-573.
16. Leckman JF, Bloch MH, Scahill L, King RA. 2006. Tourette syndrome: The self under siege. J Child Neurol 21: 642-649.
17. Liao IH, Corbett BA, Gilbert DL, Bunge SA, Sharp FR. 2011. Blood gene expression correlated with tic severity in medicated and unmedicated patients with Tourette Syndrome. Pharmacogenomics (in press).
18. Lit L, Gilbert DL, Walker W, Sharp FR. 2007. A subgroup of Tourette's patients overexpress specific natural killer cell genes in blood: A preliminary report. Am J Med Genet Part B 144B: 958-963.
19. Lit L, Enstrom A, Sharp FR, Gilbert DL. 2009. Age-related gene expression in Tourette syndrome. J Psychiatr Res 43: 319-330.
20. Martino D, Church AJ, Defazio G, Dale RC, Quinn NP, Robertson MM, Livrea P, Orth M, Giovannoni G. 2005. Soluble adhesion molecules in Gilles de la Tourette's syndrome. J Neurol Sci 234: 79-85.
21. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF. 2009. Immunopathogenic mechanisms in Tourette syndrome: A critical review. Mov Disord 24: 1267-1279.
22. Matlin AJ, Clark F, Smith CW. 2005. Understanding alternative splicing: Towards a cellular code. Nat Rev Mol Cell Biol 6: 386-398.
23. Mejia NI, Jankovic J. 2005. Secondary tics and tourettism. Rev Bras Psiquiatr 27: 11-17.
24. Moller JC, Tackenberg B, Heinzel-Gutenbrunner M, Burmester R, Oertel WH, Bandmann O, Muller-Vahl KR. 2008. Immunophenotyping in Tourette syndrome-A pilot study. Eur J Neurol 15: 749-753.
25. Moore DF, Li H, Jeffries N, Wright V, Cooper RA, Jr., Elkahloun A, Gelderman MP, Zudaire E, Blevins G, Yu H, Goldin E, Baird AE. 2005. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: A pilot investigation. Circulation 111: 212-221.
26. Muller N. 2007. Tourette's syndrome: Clinical features, pathophysiology, and therapeutic approaches. Dialogues Clin Neurosci 9: 161-171.
27. Partek, Manual. Alternative splice analysis of exon data in Partek Genomics Suite. p11.
28. Rane MJ, Gozal D, Butt W, Gozal E, Pierce WM, Jr., Guo SZ, Wu R, Goldbart AD, Thongboonkerd V, McLeish KR, Klein JB. 2005. Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion. J Immunol 174: 7242-7249.
29. Rollins B, Martin MV, Morgan L, Vawter MP. 2010. Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet Part B 153B: 919-936.
30. Sharp FR, Lit L, Xu H, Apperson M, Walker W, Wong B, Gilbert DL, Hershey A, Glauser TA. 2006a. Genomics of brain and blood: Progress and pitfalls. Epilepsia 47: 1603-1607.
31. Sharp FR, Xu H, Lit L, Walker W, Apperson M, Gilbert DL, Glauser TA, Wong B, Hershey A, Liu DZ, Pinter J, Zhan X, Liu X, Ran R. 2006b. The future of genomic profiling of neurological diseases using blood. Arch Neurol 63: 1529-1536.
32. Singer HS. 2005. Tourette's syndrome: From behaviour to biology. Lancet Neurol 4: 149-159.
33. Stillman A, Ercan-Sencicek AG, MW S. 2009a. Tourette disorder overview. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. Gene Reviews [Internet]. Seattle, WA: University of Washington, Seattle.
34. Stillman A, Ercan-Sencicek AG, MW. S. 2009b. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol 513: 21-37.
35. Sullivan PF, Fan C, Perou CM. 2006. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet Part B 141B: 261-268.
36. Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF. 2007. Tourette syndrome and tic disorders: A decade of progress. J Am Acad Child Adolesc Psychiatry 46: 947-968.
37. Tang Y, Lu A, Ran R, Aronow BJ, Schorry EK, Hopkin RJ, Gilbert DL, Glauser TA, Hershey AD, Richtand NW, Privitera M, Dalvi A, Sahay A, Szaflarski JP, Ficker DM, Ratner N, Sharp FR. 2004a. Human blood genomics: Distinct profiles for gender, age and neurofibromatosis type 1. Brain Res Mol Brain Res 132: 155-167.
38. Tang Y, Schapiro MB, Franz DN, Patterson BJ, Hickey FJ, Schorry EK, Hopkin RJ, Wylie M, Narayan T, Glauser TA, Gilbert DL, Hershey AD, Sharp FR. 2004b. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Ann Neurol 56: 808-814.
39. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR. 2005. Blood gene expression profiling of neurologic diseases: A pilot microarray study. Arch Neurol 62: 210-215.
40. Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, Ran R, Gregg JP, Reilly M, Pancioli A, Khoury JC, Sauerbeck LR, Carrozzella JA, Spilker J, Clark J, Wagner KR, Jauch EC, Chang DJ, Verro P, Broderick JP, Sharp FR. 2006. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: A microarray study. J Cereb Blood Flow Metab 26: 1089-1102.
41. Tian J, Lu Y, Zhang H, Chau CH, Dang HN, Kaufman DL. 2004. Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 173: 5298-5304.
42. Tian Y, Green PG, Stamova B, Hertz-Picciotto I, Pessah IN, Hansen R, Yang X, Gregg JP, Ashwood P, Jickling G, Van de Water J, Sharp FR. 2009. Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res. Epub ahead of print, 2009 Nov 17. DOI: 10.1007/s12640-009-9126-x http://www.ncbi.nlm.nih.gov/pubmed/19921347
43. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. 1996. Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance. Am J Hum Genet 59: 684-693.
44. Wand R, Shady G, Broder R, Furer P, Staley D. 1992. Tourette syndrome: Issues in diagnosis. Neurosci Biobehav Rev 16: 449-451.
45. Xu H, Tang Y, Liu DZ, Ran R, Ander BP, Apperson M, Liu XS, Khoury JC, Gregg JP, Pancioli A, Jauch EC, Wagner KR, Verro P, Broderick JP, Sharp FR. 2008. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: Biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab 28: 1320-1328.
46. Yang GB, Qiu CL, Zhao H, Liu Q, Shao Y. 2006. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J Neuroimmunol 178: 24-29.
47. Zhang A. 2006. Advanced Analysis of Gene Expression Microarray Data. Singapore; Hackensack, NJ: World Scientific Press.